01.09.2015 09:16:45
|
Earnings Reported After The Bell Aug. 31
(RTTNews) - Here is a quick summary of the earnings reported after the bell on August 31.
Adept Technology, Inc. (ADEP)
GAAP net loss attributable to common shareholders was $1.4 million, or $0.10 per share, compared with net loss of $0.4 million, or $0.03 per share a year ago.
Revenues for the fourth quarter were $13.9 million, compared with $14.3 million last year.
***
Chiasma, Inc. (CHMA)
Q2 net loss attributable to common stockholders was $8.0 million, or $50.36 per share compared to net income attributable to common stockholders of $3.7 million, or $83.42 per share, for the same period a year ago.
Q2 revenue was nil vs. $5.99 million a year ago.
***
Aimmune Therapeutics, Inc. (AIMT)
Net loss was $7.4 million for the second quarteror $1.60 per share, compared to net loss of $2.8 million, or $0.94 per share, for the same period of the prior year.
***
Bazaarvoice, Inc. (BV)
Q1 GAAP net loss was $10.2 million, compared to a GAAP net loss of $10.3 million a year ago.
Q1 GAAP net loss per share was $0.13 compared to loss of $0.13 per share a year ago.
Non-GAAP net loss was $5.0 million, compared to a non-GAAP net loss of $6.7 million last year.
Non-GAAP net loss per share was $0.06 compared to net loss of $0.09 per share a year ago.
Bazaarvoice reported revenue of $48.9 million for the first quarter, up 6% from $45.98 million last year.
***
E-Commerce China Dangdang Inc. (DANG)
Net loss for the second quarter of 2015 was RMB21.2 million ($3.4 million) compared to net income of RMB28.8 million a year ago.
Q2 loss per ADS was RMB0.26 ($0.04), compared to earnings per ADS of RMB0.35 in the corresponding period of the previous year.
Non-GAAP net loss was RMB18.7 million ($3.0 million), compared to net income of RMB31.7 million a year ago.
Total net revenues for the second quarter were RMB2,312.3 million ($373.0 million), a 29.8% increase from the last year.
***
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Aimmune Therapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |